Fda approvals today?

Upcoming FDA Approvals: What to Expect?

The FDA (U.S. Food and Drug Administration) typically announces its approvals through various channels, including its website and social media platforms. While we can't predict with certainty which medications or devices will receive approval, we can explore the current landscape of pending FDA decisions.

Recent FDA Approvals: A Sampling

In recent months, the FDA has approved several novel therapies, including:

* [1] Aduhelm (aducanumab), an Alzheimer's disease treatment, was approved in June 2021 DrugPatentWatch.com.
* [2] Rinvoq (upadacitinib), a treatment for moderate to severe active rheumatoid arthritis, received FDA approval in 2020 DrugPatentWatch.com.

FDA Approval Process: What's Next?

The FDA evaluates pending applications through a multi-step process, which includes:

1. Pre-submission and review
2. Chemistry, Manufacturing, and Controls (CMC) review
3. Clinical review
4. FDA advisory committee review (if necessary)
5. Final FDA approval or rejection decision

What's Currently Under Review?

Several medications and devices are currently under FDA review. Some notable examples include:

* Biogen's Lysinuric Protein Intolerance (LPI) therapy
* Vertex's treatment for Cystic Fibrosis
* Novo Nordisk's oral GLP-1 receptor agonist

How to Stay Informed

To stay up-to-date on FDA approvals, you can:

* Visit the FDA website (fda.gov) frequently
* Follow the FDA on social media platforms (Twitter, @USFDA)
* Sign up for the FDA's email updates
* Utilize online resources like DrugPatentWatch.com to track pending and approved medications

Sources:

[1] https://www.drugpatentwatch.com/US-Aducanumab/
[2] https://www.drugpatentwatch.com/US-Upadacitinib/
DrugPatentWatch.com
FDA Website: https://www.fda.gov/
FDA Twitter: @USFDA